EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation

Takayuki Sadanaga iD, Han-Seok Jeong iD, Roberto Cortez, Joyce H Lee iD, Suchitra Kamle, Bing Ma, Sung Jae Shin, Jack A Elias, Chun Geun Lee

ImmunoTargets and Therapy · 2026-03 · Volume 15 · 1-16

DOI: 10.2147/itt.s563951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-03. Verfasst von Takayuki Sadanaga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Brown University, Providence, RI, USA. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

anti-CHI3L1chitinase 3-like 1kasugamycintumor associated macrophages

Autor:innen und Institutionen

  • Department of Molecular Microbiology and Immunology, Brown University, Providence, RI, USA.
  • Department of Acute Care Surgery, Morehouse School of Medicine, Grady Memorial Hospital, Atlanta, GA, USA.
  • Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Department of Microbiology, Institute for Immunology and Immunological Disease, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Translational Medicine, Intercollege, Hanyang University, Seoul, South Korea.

ORCID-Profile: Takayuki Sadanaga, Han-Seok Jeong, Joyce H Lee

Zitieren

APA

Sadanaga, T., Jeong, H. S., Cortez, R., Lee, J. H., Kamle, S., Ma, B., Shin, S. J., Elias, J. A., & Lee, C. G. (2026). Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation. ImmunoTargets and Therapy, Volume 15, 1-16. https://doi.org/10.2147/itt.s563951

Vancouver

Sadanaga T, Jeong HS, Cortez R, Lee JH, Kamle S, Ma B, et al. Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation. ImmunoTargets and Therapy. 2026;Volume 15:1-16. doi:10.2147/itt.s563951

BibTeX
@article{Sadanaga2026,
  author = {Sadanaga, Takayuki and Jeong, Han-Seok and Cortez, Roberto and Lee, Joyce H and Kamle, Suchitra and Ma, Bing and Shin, Sung Jae and Elias, Jack A and Lee, Chun Geun},
  title = {Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--16},
  doi = {10.2147/itt.s563951}
}
Kostenlos starten →